Rana Atique Anwer, Sajid Ghafor, Huma Ahmad 2022. Neoadjuvant Docetaxel Plus Carboplatin Versus Epirubicin Plus Cyclophosphamide Followed by Docetaxel in Triple-Negative, Early-Stage Breast Cancer. Pakistan Journal of Medical & Health Sciences. 16, 08 (Sep. 2022), 356. DOI:https://doi.org/10.53350/pjmhs22168356.